辉瑞新冠疫苗接种说明书。该疫苗由辉瑞公司制造,接种者能预防感染新冠病毒。研究结果发现:与尚未接种本疫苗的人相比,本疫苗接种者感染新冠病毒的几率很低。(研究结果报告称,本疫苗预防疾病发作的有效性约为 95%。)
This document provides vaccination instructions for the Pfizer Comirnaty COVID-19 vaccine. The vaccine is manufactured by Pfizer and is given as two intramuscular doses of 0.3 mL each, usually three weeks apart, to people aged 16 and older. Reported effectiveness in preventing COVID-19 disease onset is about 95%.
It lists groups who should not receive the vaccine, groups who should use caution, and possible adverse reactions such as pain at the injection site, headache, and fever. The sheet also describes post-vaccination precautions and lists vaccine ingredients including tozinameran (mRNA), ALC-0315, ALC-0159, DSPC, cholesterol, potassium chloride, potassium dihydrogen phosphate, sodium chloride, disodium hydrogen phosphate dihydrate, and sucrose. This manual is written in Chinese.
| Product name | Comirnaty |
|---|---|
| Reported effectiveness | About 95% |
| Dosage per shot | 0.3 mL |
| Target age | 16 years and older |
| Active ingredient | Tozinameran (mRNA) |
The vaccine is manufactured by Pfizer.
Two doses are required, usually three weeks apart.
The vaccine's effectiveness in preventing disease onset is about 95%.